Cell therapies for skin regeneration: an overview of 40 years of experience in burn units

Switzerland had one of the highest rates of cell transplantation in Europe in 2009. Cell therapies are particularly common for skin regeneration, especially at the University Hospital of Lausanne, one of two national centres specialised in burn care.

Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study

There is a large body of evidence indicating that 4 to 5% of solid organ transplant recipients develop a malignancy after transplantation, which corresponds to an approximately two- to four-fold elevated risk compared to the general population.

Use of cardiac magnetic resonance imaging and single photon emission computed tomography for the diagnosis of stable coronary artery disease in Switzerland

Single-photon emission computed tomography (SPECT) is currently the more widely used for diangosis of stable coronary artery disease, but new medical and economic evidence favours cardiac magnetic resonance imaging.

Adjuvant trastuzumab chemotherapy in early breast cancer: meta-analysis of randomised trials and cost-effectiveness analysis

A number of studies have recently evaluated the cost-effectiveness of adding trastuzumab to standard adjuvant chemotherapy of early breast cancer. However, these studies had some methodological limitations.